Jejunal access for enteral nutrition: A practical guide for percutaneous endoscopic gastrostomy with jejunal extension and direct percutaneous endoscopic jejunostomy

被引:0
|
作者
Bourgeois, Amelie [1 ]
Gkolfakis, Paraskevas [1 ]
Fry, Lucia [2 ]
Arvanitakis, Marianna [1 ]
机构
[1] Univ Libre Bruxelles ULB, Erasme Hosp, Dept Gastroenterol Hepatopancreatol & Digest Oncol, Brussels, Belgium
[2] Frankenwaldklinikum Kronach, Internal Med Gastroenterol & Geriatr, Halberstadt, Germany
关键词
Direct percutaneous endoscopic jejunostomy; Percutaneous endoscopic gastrostomy with; jejunal extension; Jejunal nutrition; DOUBLE-BALLOON ENTEROSCOPY; OUTCOMES; PEG; THERAPY; SUCCESS; DPEJ;
D O I
10.1016/j.bpg.2023.101849
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
For patients requiring long-term (>4 weeks) jejunal nutrition, jejunal medication delivery, or decompression, a percutaneous endoscopic gastrostomy with jejunal extension (PEG-J) or a direct percutaneous endoscopic jejunostomy (DPEJ) may be indicated. PEG-J is the preferred option if a PEG tube is already in place or if simultaneous gastric decompression and jejunal nutrition are needed. DPEJ is recommended for patients with altered anatomy due to foregut surgery, high risk of jejunal extension migration, and whenever PEG-J fails. Successful placement rates are lower for DPEJ but recent publications have reported improvements, partly due to the use of balloon-assisted enteroscopy. Both techniques are contraindicated in cases of active peritonitis, uncorrectable coagulopathy, and ongoing bowel ischaemia, and relative contraindications include, among other, peptic ulcer disease and haemodynamic or respiratory instability. In this narrative review, we present the most recent evidence on indications, contraindications, technical considerations, adverse events, and outcomes of PEG-J and DPEJ.
引用
收藏
页数:8
相关论文
共 50 条